Amplicon-based DNA and RNA unified NGS for enhanced fusion variant detection in suboptimal real-world NSCLC FFPE specimens
Unified DNA+RNA amplicon NGS delivered guideline-relevant biomarkers from 759 real-world NSCLC FFPE samples, including small biopsies and cytology, suggesting that a single low-input assay can often replace sequential DNA→RNA testing and reduce repeat biopsies.